- Home
- WHF vs BWAY Comparison
WHF vs BWAY Comparison
Compare WHF & BWAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WHF
- BWAY
- Stock Information
- Founded
- WHF 2011
- BWAY 2003
- Country
- WHF United States
- BWAY Israel
- Employees
- WHF N/A
- BWAY N/A
- Industry
- WHF Finance Companies
- BWAY Medical/Dental Instruments
- Sector
- WHF Finance
- BWAY Health Care
- Exchange
- WHF Nasdaq
- BWAY Nasdaq
- Market Cap
- WHF 226.2M
- BWAY 207.4M
- IPO Year
- WHF 2012
- BWAY 2019
- Fundamental
- Price
- WHF $9.31
- BWAY $8.88
- Analyst Decision
- WHF Sell
- BWAY Strong Buy
- Analyst Count
- WHF 4
- BWAY 3
- Target Price
- WHF $10.83
- BWAY $13.17
- AVG Volume (30 Days)
- WHF 68.2K
- BWAY 24.2K
- Earning Date
- WHF 05-12-2025
- BWAY 05-13-2025
- Dividend Yield
- WHF 16.54%
- BWAY N/A
- EPS Growth
- WHF N/A
- BWAY N/A
- EPS
- WHF 0.47
- BWAY 0.06
- Revenue
- WHF $92,817,000.00
- BWAY $41,016,000.00
- Revenue This Year
- WHF N/A
- BWAY $351.53
- Revenue Next Year
- WHF N/A
- BWAY $21.84
- P/E Ratio
- WHF $19.86
- BWAY $56.55
- Revenue Growth
- WHF N/A
- BWAY 29.04
- 52 Week Low
- WHF $8.44
- BWAY $5.13
- 52 Week High
- WHF $13.44
- BWAY $11.79
- Technical
- Relative Strength Index (RSI)
- WHF 40.70
- BWAY 49.99
- Support Level
- WHF $9.27
- BWAY $8.61
- Resistance Level
- WHF $9.68
- BWAY $9.28
- Average True Range (ATR)
- WHF 0.18
- BWAY 0.41
- MACD
- WHF -0.02
- BWAY 0.06
- Stochastic Oscillator
- WHF 5.88
- BWAY 72.22
About WHF WhiteHorse Finance Inc.
WhiteHorse Finance Inc is a non-diversified, closed-end management investment company. It makes debt investments in privately held; small-cap companies located in United States. Its investment objective is to generate attractive risk-adjusted returns for investors, primarily by originating senior secured loans to privately held small-cap companies across a broad range of industries.
About BWAY BrainsWay Ltd.
BrainsWay Ltd is engaged in advanced noninvasive neurostimulation treatments for mental health disorders. The company is advancing neuroscience with its proprietary Deep Transcranial Magnetic Stimulation (Deep TMS) platform technology to improve health and transform lives. Current indications include depressive disorder (including reduction of anxiety symptoms, commonly referred to as anxious depression), obsessive-compulsive disorder and smoking addiction. Additional clinical trials of Deep TMS in various psychiatric, neurological, and addiction disorders are underway. The company derives revenues from the lease and sale of Deep TMS systems.